S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Save $200 on MarketBeat All Access (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Save $200 on MarketBeat All Access (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Save $200 on MarketBeat All Access (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Save $200 on MarketBeat All Access (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Save $200 on MarketBeat All Access (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Save $200 on MarketBeat All Access (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Save $200 on MarketBeat All Access (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Save $200 on MarketBeat All Access (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Save $200 on MarketBeat All Access (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Save $200 on MarketBeat All Access (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
PwC Australia sidelines 9 directors as leak of tax information investigated
Save $200 on MarketBeat All Access (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Save $200 on MarketBeat All Access (Ad)
Poland imposes sanctions on 365 Belarusians over 'draconian' verdict against journalist
North Korea notifies neighboring Japan it plans to launch satellite in coming days
LON:ROQ

Roquefort Therapeutics (ROQ) Share Forecast, Price & News

GBX 6.75
0.00 (0.00%)
(As of 05/25/2023)
Compare
Today's Range
6.75
6.75
50-Day Range
6.55
7.42
52-Week Range
6.08
11.75
Volume
N/A
Average Volume
208,173 shs
Market Capitalization
£8.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ROQ stock logo

About Roquefort Therapeutics (LON:ROQ) Stock

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Receive ROQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ROQ Stock News Headlines

Roquefort Therapeutics has no exposure to SVB
Free SMS Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Roquefort Therapeutics establishes scientific advisory board
Roquefort Thera Regulatory News
Roquefort Therapeutics PLC
Roquefort Therapeutics inks Randox diagnostic deal
Free SMS Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Roquefort Therapeutics cancer drugs enjoy pre-clinical success
Roquefort Therapeutics CEO lays out strategy for 2023
Biotech firm Oncogeni acquired in £5.5m deal
UK Retailers Drop After August Sales Slump
Roquefort enlists Nobel prizewinner Sir Martin Evans
FTSE 100 opens lower as world bank warns of recession.
Roquefort Therapeutics plc (ROQ.L)
Roquefort Investments PLC (ROQ)
See More Headlines
Receive ROQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£637.00
Price / Sales
13,685.44
Cash Flow
GBX 4.52 per share
Book Value
GBX 5 per share

Miscellaneous

Free Float
N/A
Market Cap
£8.72 million
Optionable
Not Optionable
Beta
-0.04

Key Executives

  • Mr. Stephen Paul West B.Com (Age 49)
    CA, Exec. Chairman
  • Mr. Trevor Ajanthan Reginald
    CEO & Exec. Director
  • Prof. Martin J. Evans FRS
    Group Chief Scientific Officer & Exec. Director
  • Dr. Armand Keating M.D.
    Independent Chief Medical Officer













ROQ Stock - Frequently Asked Questions

How have ROQ shares performed in 2023?

Roquefort Therapeutics' stock was trading at GBX 6.75 at the beginning of 2023. Since then, ROQ stock has increased by 0.0% and is now trading at GBX 6.75.
View the best growth stocks for 2023 here
.

What is Roquefort Therapeutics' stock symbol?

Roquefort Therapeutics trades on the London Stock Exchange (LON) under the ticker symbol "ROQ."

How do I buy shares of Roquefort Therapeutics?

Shares of ROQ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Roquefort Therapeutics' stock price today?

One share of ROQ stock can currently be purchased for approximately GBX 6.75.

How much money does Roquefort Therapeutics make?

Roquefort Therapeutics (LON:ROQ) has a market capitalization of £8.72 million and generates £637.00 in revenue each year. The company earns £-1,150,000.00 in net income (profit) each year or GBX (2.80) on an earnings per share basis.

How can I contact Roquefort Therapeutics?

The official website for the company is www.roquefortinvest.com. The company can be reached via phone at 44 20 3290 9339.

This page (LON:ROQ) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -